AlzeCure Pharma

AlzeCure Pharma, a Swedish pharmaceutical company, has announced the receipt of patent approval awards for its clinical drug candidate ACD856 in several countries, including China. The drug, which holds potential as a treatment for Alzheimer’s disease and other cognitive impairment-related disorders, has been granted protection until 2039 in China, India,…